|
시장보고서
상품코드
1998686
인공 심폐 장치 시장 비즈니스 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)Heart-lung Machine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 인공 심폐 장치 시장은 2025년에 3억 8,530만 달러로 평가되었고, CAGR 4.7%로 성장하여 2035년까지 6억 670만 달러에 달할 것으로 예측됩니다.
이 시장의 확대는 주로 심혈관 질환의 유병률 증가와 전 세계 장기 이식 및 개흉 수술 건수 증가에 의해 주도되고 있습니다. 심폐우회장치(CPB)라고도 불리는 심폐우회장치는 수술 중 혈액에 산소를 공급하고 이산화탄소를 제거하며 순환을 유지함으로써 일시적으로 심장과 폐의 기능을 대신합니다. 산소화 시스템 개선, 첨단 혈액 펌프 설계 등의 기술 혁신으로 효율성, 안전성, 사용 편의성이 향상되고 있습니다. 현재 콤팩트하고 고성능의 장치로 보다 정밀한 순환 제어가 가능해져 수술 합병증 감소 및 다양한 의료현장에서 보급이 진행되고 있습니다. 저침습 수술에 대한 수요 증가와 수술 전후 결과의 개선이 맞물려 전 세계적으로 인공심폐장치의 사용은 지속적으로 증가하고 있습니다. 또한, 보험급여 제도 개선, 외래 수술 시설의 확대, 주요 기업들의 전략적 투자가 꾸준한 시장 성장을 뒷받침하고 있습니다.
| 시장 범위 | |
|---|---|
| 개시 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 개시 시점 시장 규모 | 3억 8,530만 달러 |
| 예측액 | 6억 670만 달러 |
| CAGR | 4.7% |
단일 롤러 펌프 부문은 CAGR 4.4%로 성장하여 2035년까지 3억 5,400만 달러에 달할 것으로 예측됩니다. 그 인기는 신뢰할 수 있는 제어된 혈류, 비용 효율성 및 심장 수술에 광범위하게 사용되기 때문입니다. 이 펌프는 장시간 순환이 필요한 시술에 필수적인 안정적인 체외막형 인공호흡기(ECMO)를 제공하기 때문에 병원과 신생 의료시설에서 선호되는 선택이 되고 있습니다.
외래수술센터(ASC) 부문은 2025년에 1억 4,560만 달러를 차지했으며, 2035년까지 연평균 5.3% 성장하여 2억 4,300만 달러에 달할 것으로 예측됩니다. 이 부문의 성장은 외래 진료 환경에서의 최소침습적 심장 수술의 채택 확대와 효율적인 수술 전후 관리를 지원하는 소형의 비용 효율적인 심폐 바이패스 장치 솔루션에 의해 주도되고 있습니다.
미국의 심폐 바이패스 장치 시장은 2025년에 1억 4,460만 달러에 달했으며, 2026년부터 2035년까지 연평균 4.1% 성장할 것으로 예측됩니다. 연간 심장 수술 건수, 유리한 상환 정책, 막대한 R&D 투자, 주요 제조업체의 존재로 인해 미국은 심폐 바이패스 장치의 주요 시장으로서의 입지를 확고히 하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산 및 예측 : 유형별, 2022-2035
제6장 시장 추산 및 예측 : 용도별, 2022-2035
제7장 시장 추산 및 예측 : 최종 용도별, 2022-2035
제8장 시장 추산 및 예측 : 지역별, 2022-2035
제9장 기업 개요
LSH 26.04.23The Global Heart-lung Machine Market was valued at USD 385.3 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 606.7 million by 2035.
The market expansion is driven primarily by the rising prevalence of cardiovascular diseases and the increasing number of organ transplants and open-heart surgeries worldwide. Heart-lung machines, also referred to as cardiopulmonary bypass (CPB) devices, temporarily assume the functions of the heart and lungs during surgery by oxygenating blood, removing carbon dioxide, and maintaining circulation. Technological innovations, including improved oxygenator systems and advanced blood pump designs, have enhanced efficiency, safety, and usability. Compact and high-performance devices are now enabling more precise circulation control, reduced surgical complications, and broader adoption in diverse healthcare settings. The growing demand for minimally invasive procedures, coupled with improved perioperative outcomes, continues to propel the use of heart-lung machines globally. Additionally, better reimbursement frameworks, expanding outpatient surgical facilities, and strategic investments by key players are supporting steady market growth.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $385.3 Million |
| Forecast Value | $606.7 Million |
| CAGR | 4.7% |
The single roller pump segment is expected to grow at a CAGR of 4.4% to reach USD 354 million by 2035. Its popularity stems from reliable, controlled blood flow, cost-effectiveness, and widespread use in cardiac surgeries. These pumps offer stable extracorporeal membrane oxygenation, which is crucial for procedures requiring prolonged circulation, making them a preferred choice across hospitals and emerging healthcare facilities.
The ambulatory surgical centers segment accounted for USD 145.6 million in 2025 and is projected to reach USD 243 million by 2035, growing at a CAGR of 5.3%. Growth in this segment is fueled by the increasing adoption of minimally invasive cardiac procedures in outpatient settings, alongside compact, cost-efficient heart-lung machine solutions that support efficient perioperative care.
U.S. Heart-lung Machine Market reached USD 144.6 million in 2025 and is expected to grow at a CAGR of 4.1% from 2026 to 2035. High annual cardiac surgery volumes, favorable reimbursement policies, substantial R&D investment, and the presence of major manufacturers strengthen the U.S. position as a leading market for heart-lung machines.
Prominent players operating in the Global Heart-lung Machine Market include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, Hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, Raumedic, and TERUMO. Key strategies adopted by companies in the Global Heart-lung Machine Market include continuous R&D for advanced oxygenation and pump technologies, development of compact and portable devices for outpatient facilities, strategic partnerships with hospitals and surgical centers, expansion of global distribution networks, and ensuring regulatory compliance across multiple regions. Firms also focus on offering training programs, technical support, and after-sales services to improve adoption and customer loyalty, while optimizing production efficiency and supply chains to enhance competitiveness and market penetration.
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research approach
- 1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
- 1.2.1.1 Source consistency protocol
- 1.2.1 GMI AI policy & data integrity commitment
- 1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
- 1.4 Data collection
- 1.4.1 Partial list of primary sources
- 1.5 Data mining sources
- 1.5.1 Paid sources
- 1.5.1.1 Sources, by region
- 1.5.1 Paid sources
- 1.6 Base estimates and calculations
- 1.6.1 Base year calculation for any one approach
- 1.7 Forecast model
- 1.7.1 Quantified market impact analysis
- 1.7.1.1 Mathematical impact of growth parameters on forecast
- 1.7.1 Quantified market impact analysis
- 1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Type trends
- 2.2.3 Application
- 2.2.4 End use trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of cardiovascular disease
- 3.2.1.2 Growing number of organ transplant surgeries
- 3.2.1.3 Technological advancements in heart-lung machines
- 3.2.1.4 Rising geriatric population base
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost of advanced heart-lung machines
- 3.2.2.2 Availability of alternative and minimally invasive procedures
- 3.2.3 Market opportunities
- 3.2.3.1 Expansion of transplant programs boosting requirements for advanced perfusion systems
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.5 Technology landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
- 3.6 Future market trends (Driven by Primary Research)
- 3.7 Pricing analysis, 2025 (Driven by Primary Research)
- 3.8 Impact of AI and generative AI on the market
- 3.9 Customer insights (Driven by Primary Research)
- 3.10 Porter's analysis
- 3.11 PESTEL analysis
- 3.12 Gap analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.4 Competitive positioning matrix
- 4.5 Competitive analysis of major market players
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product type launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Single roller pump
- 5.3 Double roller pump
Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Cardiac surgeries
- 6.3 Lung surgeries
- 6.4 Acute respiratory failure treatment
- 6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals and clinics
- 7.3 Ambulatory surgical centers
- 7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
Chapter 9 Company Profiles
- 9.1 BRAILE
- 9.2 Edwards
- 9.3 ELITE LIFE CARE
- 9.4 EUROSETS
- 9.5 FRESENIUS MEDICAL CARE
- 9.6 GETINGE
- 9.7 HEART CARE INDIA CO
- 9.8 hemovent
- 9.9 Jarvik HEART
- 9.10 LivaNova
- 9.11 Medtronic
- 9.12 NIPRO
- 9.13 Palex
- 9.14 Philips
- 9.15 raumedic
- 9.16 TERUMO
